Flok Health lands $12.5M to scale AI-operated physiotherapy across the NHS
What's the deal? Flok Health, a UK-based AI-operated digital physiotherapy platform, has raised $12.5M in an oversubscribed Series A led by Albion VC. Existing investors Eka VC and Form VenturesDealroom has a profile for this one. Try Dealroom → joined alongside new backer Mercia VenturesDealroom has a profile for this one. Try Dealroom →.
Founded by former medic and athlete Finn Stevenson, technologist Ric da Silva, and a team of physiotherapy and AI specialists, Flok has built a mobile app that simulates a live physiotherapy consultation. It uses real footage of a physiotherapist and responds in real time to patient inputs — without clinician oversight.
The funding will go towards expanding Flok's back pain service across the UK, launching new clinical pathways for hip and knee pain and women's pelvic health, and entering international markets.
Why now? NHS waiting lists for musculoskeletal care remain stubbornly long, and clinical capacity can't keep up with demand. Flok is already live across eleven NHS regions, serving more than 2.4 million patients with on-demand back pain treatment.
Results have been strong: during a recent NHS rollout, over 80% of patients said the AI clinic was as good as or better than traditional in-person physiotherapy. The deployment also freed up significant clinical time for more complex cases.
What could go wrong? Delivering autonomous care without clinician oversight is a bold bet. While Flok holds Class IIa medical device certification and is approved by the UK's Care Quality Commission, scaling into new conditions like pelvic health will bring fresh regulatory and clinical scrutiny.
Patient trust is another variable. Convincing people to rely on AI for healthcare — especially for new, more sensitive pathways — may prove harder than initial back pain results suggest.
The signal: Flok's oversubscribed round reflects growing investor appetite for healthtech that can prove real-world clinical impact inside public health systems, not just pilot-stage promise. With Mercia Ventures — an investment fund focused on regional UK innovation — joining the cap table alongside returning backers, the syndicate signals confidence that autonomous AI care can scale beyond a single condition and geography. For an early-growth company already embedded across eleven NHS regions, the key test now is whether that traction translates as it moves into more complex and sensitive clinical pathways.
Read more: Tech.eu
